ASCO abstracts highlight late-stage Sanofi Oncology pipeline
16 May 2012 | By Sanofi
Progress on Jevtana®, Zaltrap™ and JAK2 inhibitor featured...
List view / Grid view
News
Bristol-Myers Squibb Foundation announces $15 million expansion of Together on Diabetes® to China and India
15 May 2012 | By Bristol-Myers Squibb Company
Expansion of Together on Diabetes® initiative to China and India ...
Syrris Asia Heater – flow chemistry 1000x faster
15 May 2012 | By kdm communications limited
Syrris, has developed the fast, flexible and accurate Asia Heater...
Pfizer provides topline results from Phase 3 study of Torisel® as second-line treatment in advanced renal cell carcinoma (RCC)
15 May 2012 | By Pfizer
Pfizer Inc announced that the Phase 3 INTORSECT study...
GlaxoSmithKline to fully acquire Cellzome for £61 million
15 May 2012 | By GlaxoSmithKline
GSK to further expand its platform technology expertise with acquisition of chemical proteomics company...
U.S. FDA approves Bristol-Myers Squibb Devens biologics manufacturing facility
15 May 2012 | By Bristol-Myers Squibb Company
State-of the art Manufacturing Facility Supports Company’s Growing Focus on Biologics...
Abbott’s XIENCE PRIME™ and XIENCE V® Drug Eluting Stents receive indication in Europe
15 May 2012 | By Abbott
New indication supported by data from more than 10,000 patients...
Updates on three of six ongoing Phase III Ramucirumab trials to be presented
14 May 2012 | By Eli Lilly and Company
Eli Lilly and Company will present data from several molecules...
Bristol-Myers Squibb and Tsinghua University enter strategic partnership
14 May 2012 | By Bristol-Myers Squibb
Under the agreement, Bristol-Myers Squibb will fund research efforts at Tsinghua University’s School of Life Sciences...
Lilly Oncology to highlight final results for Phase III study in most common form of lung cancer
14 May 2012 | By Eli Lilly and Company
Eli Lilly and Company will present data from more than 25 studies...
Pfizer to present new data in advanced kidney, lung and Hhmatologic cancers
14 May 2012 | By Pfizer
New data will be presented on targeted cancer treatments from the Pfizer Oncology portfolio across three key therapeutic categories...
Statistically significant clinical phase III results of Lu AA21004
14 May 2012 | By H. Lundbeck A/S
H. Lundbeck A/S announced positive top-line results from three recently completed phase III clinical studies of Lu AA21004...
Bristol-Myers Squibb to present new data on ORENCIA®
14 May 2012 | By Bristol-Myers Squibb Company
Bristol-Myers Squibb Company announced that the company will present 18 abstracts on ORENCIA®...
New AVONEX® dosing innovations for people with Multiple Sclerosis now available in US
14 May 2012 | By Biogen Idec
Two new dosing innovations designed to help patients receiving once-a-week AVONEX...
Academia-pharma collaboration attracts £14.4million funding in the UK to accelerate drug discovery
14 May 2012 | By University of Dundee
The consortium includes six companies & will provide core support of £14.4 million...
